Logo

IP Roundup: Siemens, Affymetrix, Gen9

May 07, 2014
Premium

Title: Process for determining the concentration of nucleic acids.
Patent Number: 8,715,924
Filed: June 13, 2007
Lead Inventor: Walter Gumbrecht, Siemens

Title: Amplification and analysis of selected targets on solid supports.
Patent Number: 8,716,190
Filed: Oct. 6, 2010
Lead Inventor: Glenn Fu, Affymetrix

Title: Methods and devices for nucleic acid synthesis.
Patent Number: 8,716,467
Filed: March 2, 2011
Lead Inventor: Joseph Jacobson, Gen9

Filed under

Microarrays & Multiplexing
microarrays
Siemens
Thermo Fisher Scientific
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.